Position in BNTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$52,201
+$29,004 QoQ
Shares Held
561
+114.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#211
of 282 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. BNTX ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,962,177 | $344,511,290 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,389 | $2,676,877 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $2,668,552 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,063 | $662,823 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
1,699 | $631,467 | |
| 6 | ARGX |
Argenx SE
|
640 | $593,772 | |
| 7 | INCY |
Incyte Corp
|
4,961 | $562,378 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
13,833 | $539,625 |
All Filings in BNTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,201 | 561 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $23,197 | 261 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,332 | 14 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,380 | 14 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,597 | 15 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $273 | 3 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $29,057 | 255 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $29,930 | 252 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $13,821 | 172 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $15,867 | 172 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $18,152 | 172 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $19,555 | 180 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $16,081 | 149 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $18,560 | 149 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $29,593 | 197 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $47,477 | 352 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $52,483 | 352 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $54,920 | 322 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $91,003 | 353 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $85,991 | 315 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $72,761 | 325 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $35,486 | 325 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $4,076 | 50 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $5,192 | 75 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $5,005 | 75 | Shares | Sole | 2020-07-16 | |
| No filing history on record for this holder in this stock. | ||||||